There is insufficient scientific evidence indicating that the sliding scale therapy (SSI) is effective in improving blood sugar levels, based on a 2010 article published in the American Family Physician. On the contrary, the results of the study suggest that this form of treatment directly contributes to the extended hospitalization of diabetic patients.
In the United States, SSI remains predominantly used in medical facilities despite consistent clinical recommendations to discontinue this traditional practice. Experts derived their data and conclusions from over four decade's worth of research regarding the therapy.
The study shows that SSI is ineffective in managing high blood glucose. This poor glycemic control is associated with the therapy's lack of an individualized scale. SSI does not accommodate personal factors that may influence insulin needs, including a patient's weight, dietary intake and insulin history, notes Healthline.